Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.043 USD | +167.08% | +167.08% | +95.45% |
2023 | THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding | CI |
2021 | Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman | CI |
Sales 2013 | 21.64K 29.56K | Sales 2014 | 19.03K 26K | Capitalization | 9.86M 13.47M |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | - 0 | EV / Sales 2013 * | - |
Net Debt 2013 | 58.16K 79.45K | Net Debt 2014 | 77.06K 105K | EV / Sales 2014 | 522 x |
P/E ratio 2013 * |
-
| P/E ratio 2014 |
-321
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 20.62% |
1 day | +167.08% | ||
1 week | +167.08% | ||
Current month | +255.37% | ||
1 month | +255.37% | ||
3 months | +175.64% | ||
6 months | +283.93% | ||
Current year | +95.45% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Grossman
CEO | Chief Executive Officer | - | - |
Gary Henrie
LAW | General Counsel | 70 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Tobias
BRD | Director/Board Member | 73 | - |
Mark Grossman
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+95.45% | 780K | |
+13.25% | 2.91B | |
+14.12% | 1.69B | |
+84.57% | 625M | |
+3.64% | 485M | |
+29.11% | 159M | |
+13.51% | 108M | |
+52.81% | 56.96M |
- Stock Market
- Equities
- CBDG Stock